1. Animal studies have shown that angiotensin II has a biphasic effect
on urinary sodium excretion. To examine whether this is also true in
man, we studied seven salt-replete male subjects in a single-blind pla
cebo-controlled manner. 2. While undergoing maximum diuresis, subjects
were infused with 0, 1, 2, 5 or long of angiotensin II min-1 kg-1 ove
r 80 min. Subjects were studied while seated, and stood every 20 min f
or urine collection. 3. Angiotensin II produced a dose-dependent antid
iuretic effect. The urine flow rate, in ml/min expressed as the change
from baseline with increasing dose of angiotensin, was: +3.4+/-1.77,
-1.26+/-0.49 (P< 0.05), -2.75+/-1.23 (P<0.05), -4.21+/-0.82 (P<0.05) a
nd -6.51+/-1.07 (P<0.01). 4. In contrast, the effect of angiotensin II
on sodium excretion showed a flat dose-response curve beyond 5 ng min
-1 kg-1. The urinary sodium excretion, in mumol/min expressed as the c
hange from baseline with increasing dose of angiotensin, was: 9.5+/-21
.2, -18.9+/-29.6, -37.0+/-11.6 (P<0.05), -67.7+/-19.6 (P<0.01) and -63
.8+/-14.3 (P<0.01). 5. The fractional distal reabsorption of sodium, d
etermined by using the lithium clearance technique, showed a rise with
all doses of angiotensin II used and reached statistical significance
with the top two doses. 6. Unlike antidiuresis, antinatriuresis after
graded doses of angiotensin II in human subjects showed a flat dose-r
esponse curve beyond 5 ng min-1 kg-1. Pressor doses of angiotensin II
also have a significant effect on the distal tubule in promoting sodiu
m reabsorption.